Aviva Earnings Calls
| Release date | Mar 05, 2026 |
| EPS estimate | $0.423 |
| EPS actual | $0.375 |
| EPS Surprise | -11.39% |
| Revenue estimate | 39.399B |
| Revenue actual | 39.399B |
| Release date | Aug 12, 2025 |
| EPS estimate | $0.371 |
| EPS actual | $0.353 |
| EPS Surprise | -4.72% |
| Revenue estimate | 37.669B |
| Revenue actual | 16.851B |
| Revenue Surprise | -55.26% |
| Release date | Feb 27, 2025 |
| EPS estimate | $0.300 |
| EPS actual | $0.0243 |
| EPS Surprise | -91.89% |
| Revenue estimate | 33.87B |
| Revenue actual | 26.169B |
| Revenue Surprise | -22.74% |
| Release date | Nov 14, 2024 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for Aviva
Below you can see how AIVAF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Nov 14, 2024 |
| Price on release | $5.84 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Nov 08, 2024 | $5.84 |
| Nov 11, 2024 | $5.84 |
| Nov 12, 2024 | $5.84 |
| Nov 13, 2024 | $5.84 |
| Nov 14, 2024 | $5.84 |
| Nov 15, 2024 | $5.84 |
| Nov 18, 2024 | $5.84 |
| Nov 19, 2024 | $5.84 |
| Nov 20, 2024 | $5.84 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
| Release date | Feb 27, 2025 |
| Price on release | $6.32 |
| EPS estimate | $0.300 |
| EPS actual | $0.0243 |
| EPS surprise | -91.89% |
| Date | Price |
|---|---|
| Feb 21, 2025 | $6.20 |
| Feb 24, 2025 | $6.32 |
| Feb 25, 2025 | $6.32 |
| Feb 26, 2025 | $6.32 |
| Feb 27, 2025 | $6.32 |
| Feb 28, 2025 | $6.32 |
| Mar 03, 2025 | $6.32 |
| Mar 04, 2025 | $6.75 |
| Mar 05, 2025 | $7.05 |
| 4 days before | 1.94% |
| 4 days after | 11.55% |
| On release day | 0% |
| Change in period | 13.71% |
| Release date | Aug 12, 2025 |
| Price on release | $8.89 |
| EPS estimate | $0.371 |
| EPS actual | $0.353 |
| EPS surprise | -4.72% |
| Date | Price |
|---|---|
| Aug 06, 2025 | $8.42 |
| Aug 07, 2025 | $8.42 |
| Aug 08, 2025 | $7.96 |
| Aug 11, 2025 | $8.42 |
| Aug 12, 2025 | $8.89 |
| Aug 13, 2025 | $8.89 |
| Aug 14, 2025 | $8.89 |
| Aug 15, 2025 | $9.16 |
| Aug 18, 2025 | $9.14 |
| 4 days before | 5.58% |
| 4 days after | 2.76% |
| On release day | 0% |
| Change in period | 8.49% |
| Release date | Mar 05, 2026 |
| Price on release | $9.08 |
| EPS estimate | $0.423 |
| EPS actual | $0.375 |
| EPS surprise | -11.39% |
| Date | Price |
|---|---|
| Feb 27, 2026 | $9.08 |
| Mar 02, 2026 | $9.08 |
| Mar 03, 2026 | $9.08 |
| Mar 04, 2026 | $9.08 |
| Mar 05, 2026 | $9.08 |
| Mar 06, 2026 | $8.24 |
| Mar 09, 2026 | $8.24 |
| Mar 10, 2026 | $8.24 |
| Mar 11, 2026 | $8.68 |
| 4 days before | 0% |
| 4 days after | -4.38% |
| On release day | -9.25% |
| Change in period | -4.38% |
Aviva Earnings Call Transcript Summary of Q4 2025
Aviva reported a strong 2025, with operating profit up 25% to GBP 2.2bn, EPS of 56p and IFRS ROE of 17.5%. The results include six months of Direct Line and management says the group has already met its 2026 targets a year early and has raised multi‑year ambitions. Key capital actions: a final dividend of 26.2p (total 39.3p, +10% YoY) and resumption of a GBP 350m share buyback. Solvency sits around 180% with continued own funds generation and explicit plans to deliver at least GBP 350m (c.7 points) of Direct Line solvency synergies by year‑end and ~20 points of operating capital generation in 2027. Business highlights: General Insurance premiums +18% (U.K. combined ratio ~93.9% on a U.K. basis; Group COR guidance for 2026: better than 94%); Wealth AUM >GBP 230bn with record net flows (~GBP 11bn) and on track to GBP 280m Wealth profit ambition by 2027; Retirement wrote GBP 4.6bn of bulk annuities at attractive mid‑teens IRRs; Protection & Health margins improving and integration of AIG protection nearing completion. Direct Line integration is progressing: pricing models implemented, asset transfers to Aviva Investors, early cost savings delivered (first GBP 50m H2 2025) and GBP 225m total cost‑saving ambition confirmed, with c.GBP 50m p.a. incremental claims investment planned. Management emphasises AI as a strategic enabler (partnership with OpenAI), citing tangible early benefits (medical underwriting time halved; call wrap time down ~20% in Direct Wealth) and plans to pilot an in‑house AI claims agent later in the year. Management reiterates discipline on underwriting, focus on margins over volume, continued investment in technology and data, and confidence in progressive earnings growth (new 3‑year targets).
Sign In
Buy AIVAF